CircNMD3 relieves endothelial cell injury induced by oxidatively modified low-density lipoprotein through regulating miR-498/ BMP and activin membrane-bound inhibitor (BAMBI) axis.

Xiu, Jian; Yang, Zheng; Sui, Yanbo; Zhang, Lin; Zhou, Yixing

Xiu, Jian; Yang, Zheng; Sui, Yanbo; Zhang, Lin; Zhou, Yixing.

Affiliation

Xiu J; Department of Cardiology, First People's Hospital of Zhaoqing.
Yang Z; Department of Vascular Surgery, Baoding Second Hospital.
Sui Y; Department of Cardiology, First People's Hospital of Zhaoqing.
Zhang L; Department of cardiology, First Affiliated Hospital of Daqing Heilongjiang, China.
Zhou Y; Department of Cardiology, Daqing Oilfield General Hospital, China.

Bioengineered ; 13(5): 12558-12571, 2022 05.

Article in En | MEDLINE | ID: mdl-35603423

Subject(s)

Atherosclerosis; MicroRNAs; Activins/metabolism; Activins/pharmacology; Apoptosis/genetics; Atherosclerosis/genetics; Atherosclerosis/metabolism; Cell Proliferation/genetics; Cells, Cultured; Human Umbilical Vein Endothelial Cells/metabolism; Humans; Lipoproteins, LDL/metabolism; Membrane Proteins/metabolism; MicroRNAs/metabolism

Key words

Atherosclerosis; BAMBI; circNMD3; hsa-miR-498; vascular endothelial cell injury

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MicroRNAs / Atherosclerosis Limits: Humans Language: En Journal: Bioengineered Year: 2022 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google